Viewing Study NCT02235961


Ignite Creation Date: 2025-12-24 @ 12:14 PM
Ignite Modification Date: 2025-12-28 @ 2:49 PM
Study NCT ID: NCT02235961
Status: COMPLETED
Last Update Posted: 2017-07-27
First Post: 2014-09-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module